Kornitzer Capital Management Inc Biogen Inc. Transaction History

Kornitzer Capital Management Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	BUY	$222.59 - $267.94 $139,118 - $167,462	625 Added 43.1%	2,075 $536,000
Q3 2023 Oct 31, 2023	BUY	$253.3 - $285.89 $367,285 - $414,540	1,450 New	1,450 $372,000
Q4 2020 Jan 29, 2021	SELL	$236.26 - $355.63 $472,520 - $711,260	-2,000 Closed	0 $0
Q4 2019 Jan 31, 2020	SELL	$220.06 - $304.07 $2.49 Million - $3.44 Million	-11,326 Reduced 84.99%	2,000 $593,000
Q3 2019 Nov 04, 2019	SELL	$217.44 - $243.88 $228,312 - $256,074	-1,050 Reduced 7.3%	13,326 $3.1 Million
Q2 2019 Jul 31, 2019	SELL	$219.29 - $241.72 $116,442 - $128,353	-531 Reduced 3.56%	14,376 $3.36 Million
Q1 2019 May 01, 2019	SELL	$216.71 - $338.96 $22,754 - $35,590	-105 Reduced 0.7%	14,907 $3.52 Million
Q4 2018 Jan 31, 2019	SELL	$278.5 - $352.75 $1,392 - $1,763	-5 Reduced 0.03%	15,012 $4.52 Million
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $180,508 - $236,055	-615 Reduced 3.93%	15,017 $5.31 Million
Q2 2018 Aug 02, 2018	SELL	$257.52 - $306.91 $4.11 Million - $4.9 Million	-15,978 Reduced 50.55%	15,632 $4.54 Million
Q1 2018 Apr 30, 2018	BUY	$260.13 - $367.91 $62,431 - $88,298	240 Added 0.77%	31,610 $8.66 Million
Q4 2017 Jan 31, 2018	SELL	$307.64 - $344.58 $1.13 Million - $1.27 Million	-3,680 Reduced 10.5%	31,370 $9.99 Million
Q3 2017 Oct 31, 2017	BUY	$281.15 - $329.69 $9.85 Million - $11.6 Million	35,050	35,050 $11 Million

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

Stay updated on Kornitzer Capital Management Inc with notifications on news.